Genelux Corporation (GNLX) - News Archive

Showing 3 of 3 results.

Genelux Corporation’s $10.5 Million Offering: Strategic Resilience Amid Market Challenges,

Genelux Corporation Secures $10.5 Million Through Underwritten Offering Amid Market Volatility, Showcases Strategic ResilienceOn March 25, 2025, Genelux Corporation (Nasdaq: GNLX), a late clinical-stage immuno-oncology...

Mar 25, 2025 • Major Pharmaceutical Preparations Industry Shares Genelux private placement

Genelux Corp A Strategic Shift Reinforces Optimism Amidst Market Volatility

The Genelux Corporation has been making waves in the market recently, with several significant developments that are worth paying attention to. In this article, we will outline the facts surrounding these events and ass...

Jun 24, 2024 • Major Pharmaceutical Preparations Industry Stocks on the Move C Zak Lourie S Sean Ryder Sean Ryder May

Genelux Corporation grants inducement awards to new employees, signaling expansion and advancement in immuno-oncology sector

WESTLAKE VILLAGE, Calif., Sept. 14, 2023 - Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, has recently made a significant announcement regarding the granting of inducement awards to s...

Sep 14, 2023 Shares biotech